Induction of β-Cell Proliferation and Retinoblastoma Protein Phosphorylation in Rat and Human Islets Using Adenovirus-Mediated Transfer of Cyclin-Dependent Kinase-4 and Cyclin D1

Diabetes

Volumn 53, Issue 1, 2004, Pages 149-159

  Cozar Castellano, Irene ^a   Takane, Karen K ^a   Bottino, Rita ^b   Balamurugan, A N ^c   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; INSULIN; RETINOBLASTOMA PROTEIN; THYMIDINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CELL DIVISION; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA PRIMERS; HUMANS; ISLETS OF LANGERHANS; KINETICS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RATS; RECOMBINANT PROTEINS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0347990598     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.1.149     Document Type: Article

References (31)

1. Garcia-Ocaña A, Vasavada RC, Takane KK, Cebrian A, Lopez-Talavera JC, Stewart AF: Using beta-cell growth factors to enhance human pancreatic Islet transplantation. J Endocrinol Metab 86:984-988, 2001
2. Vasavada RC, Garcia-Ocana A, Takane KK, Cebrian A, Lopez-Talavera J-C, Stewart AF: Islet growth factors. In Type I Diabetes: Etiology and Treatment. Sperlng MA, Ed. Totowa, NJ, Humana Press, 2003, p. 561-577
3. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44:249-256, 1995
4. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534, 1999
5. Adams PD: Regulation of the retinoblastoma tumor suppressor protein by cyclins/cdks. Biochim Biophys Acta 1471:M123-M133, 2001
6. Cheng T, Scadden DT: Cell cycle entry of hematopetic stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors. Int J Hematol 75:460-465, 2002
7. Hanahan D: Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122, 1985
8. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S: Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037-9041, 1988
9. Efrat S: Genetic engineering of beta cells for cell therapy of diabetes: cell growth, function and immunogenicity. Diabetes Rev 4:224-234, 1996
10. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboll A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson ML, Leone G: Extra-embryonic function of Rb is essential for embryonic development nad viability. Nature 421:942-947, 2003
11. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151, 1995
12. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484, 1994
13. Chung DC, Brown SB, Grahme-Cooke F, Seto M, Warshaw AL, Jensen RT, Arnold A: Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Endocrinol Metab 85:4373-4378, 2000
14. Rane S, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in beta cell hyperplasia. Nat Genet 22:44-52, 1999
15. Tsutsui T, Hesabi B, Moons D, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H: Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 19:7011-7019, 1999
16. Frankin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y: Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158, 2000
17. KIP2 expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769, 2001
18. Ricordi C, Rastellini C: Methods in pancreatic islet separation. In Methods in Cell Transplantation. Ricordi C, Ed. Austin, TX, R.G. Landes, 2000, p. 433-438
19. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD: Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51:2561-2567, 2002
20. Garcia-Ocaña A, Takane KK, Reddy VT, Lopez-Talavera J-C, Vasavada RC, Stewart AF: Adenovirus-mediated hepatocyte growth factor transfer to murine islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278:343-351, 2003
21. Garcia-Ocana A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera JC, Stewart AF: Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-2762, 2001
22. Cebrian A, Garcia-Ocaña A, Takane KK, Sipula D, Stewart AF, Vasavada RC: Overexpression of parathyroid hormone-related protein inhibits pancreatic β cell death in vivo and in vitro. Diabetes 51:3003-3013, 2002
23. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. Meth Cell Biol 43:161-189, 1994
24. Sorenson RL, Brelje TC: Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307, 1997
25. Otonkoski T, Cirulli V, Beattie M, Mally MI, Soto G, Rubin JS, Hayek A: A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology 137:3131-3139, 1996
26. Rhodes CJ: IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 24:303-311, 2000
27. Hui H, Nourparvar A, Zhao X, Perfetti R: Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic AMP-dependent protein kinase A- and phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444-1455, 2003
28. Drucker DJ: Perspectives in Diabetes: Glucagon-like peptides. Diabetes 47:159-169, 1998
29. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonnero-Weir S, Habener JF, Egan JM: Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748, 2000
30. Garcia-Ocaña A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF: Hepatocyte growth factor overexpression in the islet of transgenic mice incrcases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226-1232, 2000
31. 1 in transgenic mice. J Clin Invest 107:1093-1102, 2002